VesiculoVax - Preclinical-Stage Prophylactic Vaccines for Venezuelan, Eastern, and Western Equine Encephalitis Viruses (EEVs)

Program Status:
Preclinical studies have demonstrated single-dose protective efficacy of VesiculoVax™-vectored vaccines in an animal model of lethal encephalitic disease caused by the Venezuelan and Eastern equine encephalitis viruses.

Unmet Medical Need:
These mosquito-transmitted viruses are endemic to North, Central, and South America. Public health concern is based on the emerging infectious disease status of these viruses that is associated with climate change, and their potential use as biologic weapons.